December 12, 2007 - STALLERGENES S.A and Protein’eXpert S.A. announce they have signed a partnership agreement for developing and pharmaceutically producing mites recombinant allergens .The partnership is part of the STALLERGENES “Enhanced Allergens” innovation programme for a recombinant protein treatment for sublingual desensitisation of allergy to mites.
This second-generation treatment is made up of the recombinant allergens Der p 1 and Der p 2 in the form of a fusion protein, combined with an adjuvant and/or a mucoadhesive formulation for facilitating recognition of the allergen by the immune system... Stallergenes' Press Release - Version Française
